AXL and chronic myelogenous leukemia, BCR-ABL1 positive: AXL was characterized as a novel transforming gene in chronic myeloid leukemia cells in 1991 (1, 2), and subsequent cloning of TYRO3 (3) and MERTK in 1994 revealed their structural and functional similarities (4).